Intellia Therapeutics, Inc. Competitors
| Symbol | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|
BEAM
Beam Therapeutics Inc. |
$26.36 | $1.91 B | -14.51 | 483 | $63.52 M |
CRBU
Caribou Biosciences, Inc. |
$1.88 | $176.12 M | -1.41 | 147 | $9.99 M |
CRSP
CRISPR Therapeutics AG |
$42.43 | $4.91 B | -21.43 | 393 | $35.00 M |
DNA
Ginkgo Bioworks Holdings, Inc. |
$11.65 | $1.14 B | -1.2 | 834 | $227.04 M |
EDIT
Editas Medicine, Inc. |
$1.43 | $435.86 M | -2.56 | 246 | $32.31 M |
FATE
Fate Therapeutics, Inc. |
$1.87 | $418.90 M | -1.92 | 181 | $13.63 M |
PRME
Prime Medicine, Inc. |
$3.27 | $788.60 M | -3.01 | 214 | $2.98 M |
SANA
Sana Biotechnology, Inc. |
$1.75 | $1.55 B | -4.59 | 328 | $0 |
VERV
Verve Therapeutics, Inc. |
$6.41 | $409.24 M | -1.82 | 274 | $32.33 M |
VRTX
Vertex Pharmaceuticals Incorporated |
$402.49 | $124.65 B | 31.39 | 6100 | $11.02 B |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
